Anthelmintic Drugs Market: Launching and Approval of Anthelmintic Products by Key Players to Drive Global Market
AI-driven Drug Discovery Aids Approval of Niclosamide for COVID-19 Treatment
The ongoing COVID-19 (coronavirus) outbreak has fueled an unprecedented demand for drugs that are capable of fighting off the novel infection. Hence, AI (Artificial Intelligence) firm Gero is gaining global recognition for specializing in the AI-driven drug discovery and validating promising potentials of anthelmintic drugs for the treatment of COVID-19.
Read Report Overview - https://www.transparencymarketresearch.com/anthelmintic-drugs-market.html
As such, niclosamide is found to be potentially effective for the treatment of coronavirus in patients and has been approved in the U.S., Italy, France, and few other countries where there is a high prevalence of active COVID-19 patients.
Due to the approval of niclosamide, companies in the anthelmintic drugs market are increasing their efficacy in AI-driven drug discovery methods to capitalize on revenue generation opportunities. Companies in the anthelmintic drugs market are taking efforts to conduct clinical trials in existing drugs that may be useful in coronavirus treatment.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=50688
Sponsored Collaborations Fuel Research in New Drug Candidates for Soil-transmitted Infections
An alarmingly right prevalence of parasitic worm infections in humans has forced companies in the anthelmintic drugs market to increase their R&D capabilities for new drug candidates. For instance, in December 2019, Bayer Animal Health — a global provider of innovative solutions for animal health, revealed that the company is increasing its research efforts to provide promising anthelmintic drug candidates for the EU-sponsored collaboration called Project HELP (Helminth Elimination Platform) meant for human treatment.
Companies in the anthelmintic drugs market are entering into strategic collaborations in order to find new treatments for ascaris lumbricoides (Roundworm) infection. This explains why the revenue for roundworm target pathogen is estimated to dictate the highest value in the anthelmintic drugs market, resulting in anticipated revenue generation of ~US$ 4 Bn by the end of 2030. The growing awareness about soil-transmitted infections and filarial infections in humans is bolstering innovations in anthelmintic drugs.
Request for Analysis of COVID-19 Impact on Anthelmintic Drugs Market -https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=50688
Biologically Active Substances of Medicinal Plants Hold Promising Potentials for Drug Discovery
Plant-based products are being highly publicized for the development of anthelmintic drugs that are capable of treating nematodes. Currently, intestinal parasitic nematodes are a serious issue in human as well as animals. As such, animals dominate a higher revenue share as compared to humans in the anthelmintic drugs market, where the market is slated to progress at a CAGR of ~5% during the forecast period. However, anthelmintic drug resistance in humans and animals is a challenge for pharmaceutical companies. Hence, companies are using medicinal plant ingredients for the discovery of new anthelmintic drugs.
Companies in the anthelmintic drugs market are increasing their research efforts to study the biologically active substances of medicinal plants that possess drug-like properties and hold promising potentials for the treatment of intestinal parasitic nematodes in human as well as animals. As such, medicinal plant-derived drugs, such as artemether, tiopropium and galantamine are generating revenue streams for pharmaceutical companies.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=50688
Combination Therapy Awaits Confirmed Clinical Trials to Deploy Widespread Adoption in Veterinary Clinics
Various preventive measures are being adopted to control parasites in donkeys. Since vaccines are not readily available and there is a need for the development of better vaccines, veterinary doctors are relying on anthelmintic drugs to protect the health of donkeys. As such, companies in the anthelmintic drugs market are tapping value-grab opportunities by increasing the availability of benzimidazoles macrocyclic lactones and tetrahydropyrimidines to improve the health of donkeys.
Buy Anthelmintic Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=50688<ype=S
In order to effectively manage the issue of drug resistance in donkeys, companies in the anthelmintic drugs market are educating veterinarians to gain better knowledge of local parasite epidemiology and its correlation with anthelmintic drugs. The trend of combination therapy is surging, as veterinarians are using different combination of drugs to improve clinical numbers of donkeys. However, there is a need for confirmed clinical trials to support the validation of combination therapy. Since donkeys ingest third-stage larvae from grazing, there is a need for sound grazing management practices. The practice of FEC (Fecal Egg Count)-directed treatment is another alternative treatment, which is benefitting the health of donkeys.
Browse more Reports by Transparency Market Research:
In Situ Hybridization Market: https://www.transparencymarketresearch.com/in-situ-hybridization-market.html
Pyelonephritis Treatment Market: https://www.transparencymarketresearch.com/pyelonephritis-treatment-market.html
CFRP Orthopedic Prosthetics Market: https://www.transparencymarketresearch.com/cfrp-orthopedic-prosthetics-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/